Dr. Deol on the Curative Potential of CAR T-Cell Therapy in ALL
Abhinav Deol, MD, discusses the role of CAR T-cell therapy in pediatric patients with acute lymphoblastic leukemia.
Dr. Deol on the Utility of Tisagenlecleucel in ALL
Abhinav Deol, MD, discusses the approval of the CAR T-cell therapy tisagenlecleucel for pediatric patients with acute lymphoblastic leukemia.
Dr. Deol on the Nuances of Utilizing CAR T-Cell Therapy in Lymphoma and Leukemia
Abhinav Deol, MD, discusses the nuances of utilizing CAR T-cell therapy in lymphoma and leukemia.
Dr. Deol on the Safety of CAR T-Cell Therapy
Abhinav Deol, MD, associate professor with Karmanos Cancer Institute, discusses patient eligibility for chimeric antigen receptor (CAR) T-cell therapy in hematologic oncology.